Bone Pain in a Teenager That Is Not Growing Pains: Osteosarcoma

Medically reviewed by Dr. Michael Kachur · Frankfurt, Germany·

Most teenage knee pain is exactly what it looks like. The first explanation offered is a sports one, the first plan is rest and physiotherapy, and that plan is right almost every time. The weeks after it are where the time goes, because nobody holds the whole stretch in one view, which is what Healz was built for.

Category
Health Insights
Date
Reading time
11 min
Share

This post is about the small number of teenagers whose pain turns out to be osteosarcoma: the pain pattern that separates it from a sports injury, why the first imaging is still an ordinary X-ray, what the blood tests settle, the biopsy rule that decides which operations stay possible, and the treatment order.

Bone Pain in a Teenager That Is Not Growing Pains: Osteosarcoma

Who gets this, and why the timing is not a coincidence

Osteosarcoma is uncommon: the NCI's patient summary estimates about 440 cases a year in people aged 19 and younger in the United States, and calls it a rare type of bone cancer. It is still the most common cancer that starts in bone, which the Nature Reviews review calls the most common primary malignancy of bone at about 3 to 4.5 cases per million children and adolescents a year.

The 2022 Nature Reviews Disease Primers review of osteosarcoma records that these tumours arise most frequently within the metaphyses of long bones in children, adolescents and young adults during times of peak linear growth, the cells proliferating fastest during those spurts being the ones thought susceptible. The metaphysis is the flared part of a long bone beside the growth plate, the segment doing the lengthening.

Ask Healz.

One chat instead of ten apps. 1M+ rare cases checked. The root cause, not the label. Private.

The NCI's clinical summary puts about half of tumours in the femur, 80% of those in the distal femur, then the proximal tibia, the proximal humerus, pelvis, jaw, fibula and ribs.

A second group looks nothing like a teenager. Classic teaching describes a second incidence peak in people aged 60 and older, and the NCI's Division of Cancer Epidemiology and Genetics still describes one, from SEER patients diagnosed between 1973 and 2004, alongside a high percentage of osteosarcoma with Paget disease and of osteosarcoma as a second or later cancer in that age group. A 2024 analysis in the Journal of Bone Oncology (Kar et al., 47:100613) of SEER data from 2000 to 2021 found no consistent second peak above age 35, and argues the distribution is now unimodal. The Nature Reviews review names Paget's disease of bone and prior radiotherapy among the conditions that predispose to osteosarcoma, and says the precise incidence of malignant transformation in Paget's disease is unknown.

The pain pattern that gets filed as a sports injury

Pain is the presenting symptom, and the useful question is not how severe it is but when it happens. The Nature Reviews review describes the standard severity question, whether the pain keeps the patient up at night, as one typically answered in the affirmative in osteosarcoma. The pain often comes with swelling at the same site. The review names the trap plainly: patients might misassociate these symptoms with recent minor injuries.

In a 2010 Journal of Orthopaedic Surgery (Hong Kong) series of 30 patients with osteosarcoma around the knee, 53% had a history of minor trauma around the time symptoms started and 67% had a limp. A fracture through weakened bone is not the usual opening: the Nature Reviews review puts pathologic fracture at about 10%. A lump felt near a joint has its own long list of explanations, which our piece on a soft tissue lump versus a lipoma walks through.

An observational study in the BC Medical Journal in 2020 mapped the sequence for six children diagnosed with osteosarcoma or Ewing sarcoma at BC Children's Hospital in 2018. Each saw an average of four health care professionals before referral, not counting regular physiotherapy, and three of the six spent four to nine weeks in physiotherapy. On average 114 days passed from first symptoms to the start of chemotherapy, 81% of it inside primary care. Six patients is a very small study; its transferable part is the suspicion list: night pain, an atypical pain pattern after minor trauma, or a soft tissue mass on examination.

Why the first imaging is still an ordinary X-ray

That same BC Medical Journal paper calls a plain radiograph "the recommended first step in the workup when bone tumors are a possibility." A 2017 imaging review of musculoskeletal tumours in International Journal of Surgery Oncology (Umer et al., 2;11:e46) sets out how radiologists judge how aggressive a bone lesion looks: plain films remain the most reliable imaging method for assessment of both biological activity and probable histologic diagnosis of an osseous lesion.

The same review gives the most useful single sign: a wide zone of transition denotes an aggressive lesion. The zone of transition is the border, how abruptly the lesion stops and normal bone starts; a crisp line suggests something slow.

The Nature Reviews review describes what osteosarcoma tends to show: destruction of normal trabecular bone with poorly defined margins, periosteal new bone formation producing the characteristic Codman triangle, and a soft tissue mass whose ossification produces the radial sunburst pattern. The 2017 review cautions that the character of periosteal reaction is not always a reliable sign of how aggressive a lesion is, and notes separately that several benign lesions often appear highly aggressive, especially osteomyelitis and histiocytosis. Sorting the aggressive from the benign and the metastatic is its own discipline, covered in our guide to bone pain that is metastasis versus something benign.

An aggressive film does not end the imaging. The NCI's clinical summary asks for MRI of the primary site to include the entire bone, names FDG PET the preferred staging modality for detecting bone lesions, and says a CT scan remains necessary for evaluation of pulmonary metastasis. The Nature Reviews review is the one that explains what the whole-bone MRI buys: it reveals skip metastases and facilitates planning for the biopsy and the eventual resection. The lung is why: the NCI calls it the most common site of metastatic disease, with radiological metastases in about 20% of patients at diagnosis.

What alkaline phosphatase and LDH actually report

The 2018 SICOT-J review of osteosarcoma is clear that there is no laboratory test that is diagnostic for osteosarcoma, and OrthoInfo, from the American Academy of Orthopaedic Surgeons, agrees there are no blood tests that can make the diagnosis. The SICOT-J review describes alkaline phosphatase as a measure of osteoblastic activity and lactate dehydrogenase as a measure of osteoclastic activity; LDH is in fact a general marker of cell turnover, and in osteosarcoma a high level is read as a sign of tumour burden and a worse outlook.

What they carry is prognostic weight. The NCI's clinical summary lists LDH and alkaline phosphatase among prognostic factors, with elevated LDH correlating with poorer outcome. Alkaline phosphatase also moves with growth: a 2017 study in Clinical Chemistry and Laboratory Medicine charted age and sex specific percentiles to 18 years for exactly that reason, because growth and puberty swing the number.

The rule that decides which operations stay possible

The diagnosis needs tissue, and this is where a casual decision costs the most. The Nature Reviews review states that the biopsy should be performed after consulting the surgeon who will do the final operation, so the needle track can be removed as part of the definitive surgery. The SICOT-J review gives the same rule from the surgeon's side: choose a tract that will be included in that future surgery, because the resection must include the biopsy tract.

The reason is mechanical: a needle drags tumour cells along its path, so that path has to come out with the tumour. The NCI's clinical summary is blunt: the original biopsy incision placement is crucial, and an inappropriately performed biopsy may jeopardise a limb-sparing procedure. It also names a biopsy done at a different institution from the definitive surgery as a risk factor for local recurrence, and reports better outcomes when both happened at a centre with orthopaedic oncology experience.

The Nature Reviews review says an aggressive lesion should prompt referral to a specialist centre with multidisciplinary experience in skeletal sarcomas. The referral comes before the needle, not after the report.

The treatment order, and what the specimen reports back

The sequence is not intuitive. The SICOT-J review states the standard of care is currently neoadjuvant chemotherapy, surgery and adjuvant chemotherapy. OrthoInfo puts the preoperative course at about 10 weeks for high-grade disease. Going first, chemotherapy treats disease imaging cannot see and changes what the operation has to achieve.

Then the removed specimen is examined, and what it reports on is the chemotherapy. The NCI records a better prognosis in patients with at least 90% necrosis in the primary tumour, and links lower necrosis to higher recurrence in the first two years. OrthoInfo calls that response the best predictor of prognosis.

It is a measurement, not an instruction. The Nature Reviews review notes the line between good and poor response has varied from 90% to 98% necrosis between studies, and that because therapy changes based on necrosis grading have not been shown to modify survival outcomes, the use of necrosis grading has declined.

How Healz holds a case that arrived three appointments apart

The date the pain started, the first X-ray report and the second report weeks later normally live in three places: a parent's memory, one clinic's portal, another clinic's letter. Healz holds them in one chat, not ten apps and four portals.

Healz's memory pulls the medical facts out of every upload and dates them: when the pain began and which knee, both radiograph reports with their wording about margins and periosteal reaction, the alkaline phosphatase and LDH values. It keeps abnormal values up front and connects findings across months, so "worse at night since April" sits beside the report written in June.

Healz is equipped with Frontier AI, so the case is worked whole rather than one document at a time, and an imaging report is read for what it describes, not only its conclusion.

Healz is equipped with root-cause technology, so it does not stop at the first label. It asks what a rushed visit skips and cross-checks the case against more than a million rare cases, which is how a benign explanation and an aggressive one both stay in view until something settles it. You can bring a board-certified doctor into the same chat for a second opinion.

Frequently asked questions

Can growing pains cause knee pain in a teenager that wakes them up at night?

Night pain is what gets taken seriously. The 2022 Nature Reviews Disease Primers review notes that the question of whether pain keeps the patient up at night is typically answered yes in osteosarcoma, and the BC Medical Journal's 2020 study lists it among the features that should raise suspicion. It is not a diagnosis, but it is worth raising with a clinician rather than waiting out.

What does osteosarcoma look like on an X-ray?

Aggressive. The Nature Reviews review describes bone destruction with poorly defined margins, a Codman triangle from periosteal new bone, and a sunburst pattern from the ossifying soft tissue mass. A wide zone of transition is the general sign of an aggressive lesion, per a 2017 imaging review of musculoskeletal tumours in International Journal of Surgery Oncology.

Why does the biopsy have to be planned with the surgeon who will operate?

Because the biopsy path becomes part of the operation. The Nature Reviews review says the biopsy should follow consultation with the surgeon who will do the final operation, and the SICOT-J review says the resection must include that tract. The NCI warns that an inappropriately performed biopsy may jeopardise a limb-sparing procedure.

Most teenage knee pain is a sports story, and most of the time it is. The one that is not keeps going at night, and what catches it is somebody reading the weeks together, not one appointment at a time.

Written by Healz Team · Filed under Health Insights

Your health deserves more than guesswork

Get a real investigation, not a symptom list. Root causes found, history remembered, dots connected.

Not a medical provider. Healz.ai is an educational service. Always discuss every decision with your doctor. AI can make mistakes.

© 2026 HealzAI Inc1111B S Governors Ave #92123, Dover, DE 19904, USAMade with for better health